Precigen, Inc. financial data

Symbol
PGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
20374 Seneca Meadows Parkway, Germantown, MD
State of incorporation
VA
Fiscal year end
December 31
Former names
INTREXON CORP (to 1/22/2020)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 184 % -23.5%
Debt-to-equity 40.9 % +10.3%
Return On Assets -126 % -217%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 293M shares +17.7%
Common Stock, Shares, Outstanding 293M shares +14.2%
Entity Public Float 177M USD +9.38%
Weighted Average Number of Shares Outstanding, Basic 276M shares +11%
Weighted Average Number of Shares Outstanding, Diluted 276M shares +11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 22.1M USD -39.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -142M USD -66.3%
Income Tax Expense (Benefit) -2.04M USD -1627%
Net Income (Loss) Attributable to Parent -140M USD -64.1%
Earnings Per Share, Basic -0.55 USD/shares -48.6%
Earnings Per Share, Diluted -0.55 USD/shares -48.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.7M USD +145%
Cash, Cash Equivalents, and Short-term Investments 28.6M USD
Accounts Receivable, after Allowance for Credit Loss, Current 479K USD -51.5%
Assets, Current 34.5M USD -62.9%
Property, Plant and Equipment, Net 13.5M USD +90.3%
Operating Lease, Right-of-Use Asset 5.31M USD -26.3%
Intangible Assets, Net (Excluding Goodwill) 4.77M USD -88.2%
Goodwill 24.9M USD -32.5%
Other Assets, Noncurrent 425K USD -46.7%
Assets 83.5M USD -56.2%
Accounts Payable, Current 4.32M USD +83.8%
Employee-related Liabilities, Current 6.61M USD -0.14%
Contract with Customer, Liability, Current 407K USD -20%
Liabilities, Current 21.2M USD -35.5%
Contract with Customer, Liability, Noncurrent 2.03M USD +11.8%
Deferred Income Tax Liabilities, Net 89K USD -95.8%
Operating Lease, Liability, Noncurrent 4.76M USD -23.1%
Other Liabilities, Noncurrent 50K USD -50%
Liabilities 28.1M USD -34.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13K USD
Retained Earnings (Accumulated Deficit) -2.07B USD -7.23%
Stockholders' Equity Attributable to Parent 55.4M USD -62.5%
Liabilities and Equity 83.5M USD -56.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.1M USD +23.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 24M USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 293M shares +14.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.7M USD +139%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3M USD +225%
Deferred Tax Assets, Valuation Allowance 424M USD +5.82%
Deferred Tax Assets, Gross 434M USD +5.67%
Operating Lease, Liability 5.75M USD -22.2%
Depreciation 1.53M USD -22.6%
Payments to Acquire Property, Plant, and Equipment 4.35M USD +2725%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -136M USD -67.1%
Lessee, Operating Lease, Liability, to be Paid 7.8M USD -23.6%
Property, Plant and Equipment, Gross 36.1M USD +17.2%
Operating Lease, Liability, Current 988K USD -17.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.43M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.56M USD -22.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) -29K USD +47.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.05M USD -27.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.29M USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.26M USD +1.78%
Operating Lease, Payments 572K USD +23.5%
Additional Paid in Capital 2.13B USD +2.1%
Amortization of Intangible Assets 3.95M USD -17.8%
Depreciation, Depletion and Amortization 1.6M USD -6.78%
Deferred Tax Assets, Net of Valuation Allowance 9.1M USD -0.8%
Share-based Payment Arrangement, Expense 8.87M USD -9.82%